Task Force on Design and Analysis in Oral Health Research: Medication-Related Osteonecrosis of the Jaw

S Ruggiero; D Saxena; S Tetradis; T Aghaloo; E Ioannidou

doi:10.1177/2380084418770662

Task Force on Design and Analysis in Oral Health Research: Medication-Related Osteonecrosis of the Jaw

JDR Clin Trans Res. 2018 Jul;3(3):222-225. doi: 10.1177/2380084418770662. Epub 2018 Apr 12.

Authors

S Ruggiero^{1

2

3}, D Saxena⁴, S Tetradis⁵, T Aghaloo⁶, E Ioannidou^{7

8}

Affiliations

¹ 1 New York Center for Orthognathic and Maxillofacial Surgery, New York, NY, USA.
² 2 Stony Brook School of Dental Medicine, Stony Brook, NY, USA.
³ 3 School of Medicine, Hofstra-Northwell Health, Hempstead, NY, USA.
⁴ 4 Department of Basic Sciences and Craniofacial Biology College of Dentistry, New York University, New York, NY, USA.
⁵ 5 School of Dentistry, University of California at Los Angeles, CA, USA.
⁶ 6 Section of Oral and Maxillofacial Surgery, School of Dentistry, University of California at Los Angeles, CA, USA.
⁷ 7 Division of Periodontology, UConn Health, Farmington, CT, USA.
⁸ 8 Task Force on Design and Analysis in Oral Health Research, Princeton, NJ, USA.

Abstract

Knowledge Transfer Statement: This article discusses the proceedings of the conference organized by the Task Force on Design and Analysis in Oral Health Research on the understanding of the translational evidence on the etiology and pathogenesis of medication-related osteonecrosis of the jaw as well as the clinical protocols on patient management.

Keywords: MRONJ pathophysiology; MRONJ therapy; antiresorptive; bisphosphonates; microbiome; osteonecrosis of the jaws.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Advisory Committees
Bisphosphonate-Associated Osteonecrosis of the Jaw*
Bone Density Conservation Agents*
Diphosphonates
Humans
Oral Health

Substances

Bone Density Conservation Agents
Diphosphonates

Abstract

Publication types

MeSH terms

Substances

Grants and funding